| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.16▼ | 2.16▼ | 2.16▼ | 2.14▼ | 2.02▲ |
| MA10 | 2.18▼ | 2.16▼ | 2.16▼ | 2.19▼ | 2.08▲ |
| MA20 | 2.17▼ | 2.18▼ | 2.21▼ | 2.06▲ | 2.64▼ |
| MA50 | 2.23▼ | 2.21▼ | 2.21▼ | 2.17▼ | 2.31▼ |
| MA100 | 2.21▼ | 2.05▲ | 2.01▲ | 2.77▼ | 3.08▼ |
| MA200 | 2.01▲ | 2.07▲ | 2.20▼ | 2.23▼ | 19.18▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.003▼ | -0.006▼ | -0.011▼ | 0.014▲ | -0.079▼ |
| RSI | 38.224▼ | 41.644▼ | 42.505▼ | 49.922▼ | 46.709▼ |
| STOCH | 32.576 | 57.246 | 57.246 | 32.357 | 29.732 |
| WILL %R | -90.909▼ | -86.957▼ | -86.957▼ | -60.310 | -63.462 |
| CCI | -133.108▼ | -74.974 | -80.427 | -97.733 | -38.238 |
|
Tuesday, March 24, 2026 11:41 AM
AEMD READ THE FULL AEMD RESEARCH REPORT DSMB recommends AEMD progress clinical trial to the final third cohort Aethlon Medical (NASDAQ: AEMD) announced today that the independent Data Safety ...
|
|
Tuesday, March 24, 2026 07:02 AM
Aethlon Medical, Inc. (Nasdaq: AEMD), a clinical-stage biotechnology company developing the investigational Aethlon Hemopurifier®, an extracorporeal device for oncology and other indications, today ...
|
|
Monday, March 23, 2026 07:15 PM
Advances To Final Cohort In Oncology Clinical Trial Following Positive DSMB Review. (Investorideas Newswire) a leading investment platform for retail investors reports breaking Medical Tech Stock news ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 02/04/26 | 2.22 | 2.22 | 2.00 | 2.12 | 19,147 |
| 01/04/26 | 2.17 | 2.235 | 2.15 | 2.15 | 7,772 |
| 31/03/26 | 2.14 | 2.218 | 2.0801 | 2.19 | 11,912 |
| 30/03/26 | 2.15 | 2.21 | 2.05 | 2.11 | 17,664 |
| 27/03/26 | 2.23 | 2.3476 | 2.12 | 2.15 | 27,181 |
| 26/03/26 | 2.33 | 2.4391 | 2.27 | 2.27 | 18,174 |
| 25/03/26 | 2.215 | 2.41 | 2.215 | 2.32 | 46,834 |
| 24/03/26 | 2.26 | 2.26 | 2.15 | 2.16 | 48,318 |
| 23/03/26 | 2.22 | 2.365 | 2.16 | 2.30 | 44,264 |
| 20/03/26 | 2.215 | 2.24 | 2.11 | 2.16 | 39,301 |
|
|
||||
|
|
||||
|
|